Hypertension, high-dose corticosteroids, and renal infiltration in children with acute lymphoblastic leukemia

Main Article Content

Andry Juliansen
Murti Andriastuti
Sudung Pardede
Rini Sekartini

Abstract

Background Hypertension is a rarely recognized complication of acute lymphoblastic leukemia (ALL). The incidence of hypertension in ALL patients in Indonesia remains unknown, but the most common risk factors are corticosteroid use during induction-phase chemotherapy and renal leukemic infiltration.


Objective To determine the incidence of hypertension in children with ALL, and to assess for associations of high-dose corticosteroids, renal infiltration, and hyperleukocytosis to hypertension.


Methods This was a cross-sectional study involving 100 children aged 2-18 years. Subjects were newly diagnosed ALL patients and those underwent induction-phase chemotherapy in the Pediatric Ward or Outpatient Clinic at Cipto Mangunkusumo or Dharmais Hospitals.


Results Hypertension occurred in 6 (10%) of 60 newly diagnosed ALL patients and 8 (20%) of 40 patients who had received high-dose corticosteroids, but the difference was not statistically significant (OR=2.25; 95%CI 0.72 to 7.07; P=0.239). Hypertension was reported in 8 of 29 subjects who received dexamethasone, but in none of the subjects who received prednisone. However, the difference in these subgroups was also not statistically significant. Renal enlargement was found in 1 of 14 hypertensive patients, but it was not associated with hypertension (OR=0.80; 95%CI 0.52 to 1.24; P=0.417). Hyperleukocytosis was also not associated with hypertension (OR= 0.79; 95% CI 0.20 to 3.11; P=1.000).


Conclusion The incidence of hypertension in ALL patients was 14%. Hypertension is not associated with renal infiltration or hyperleukocytosis. Furthermore, hypertension is not associated with corticosteroid dose, though is found only in subjects who receive dexamethasone. [Paediatr Indones. 2014;54:372-6.].

Article Details

How to Cite
1.
Juliansen A, Andriastuti M, Pardede S, Sekartini R. Hypertension, high-dose corticosteroids, and renal infiltration in children with acute lymphoblastic leukemia. PI [Internet]. 31Dec.2014 [cited 16Sep.2019];54(6):372-. Available from: https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/505
Section
Articles
Received 2016-09-08
Accepted 2016-09-08
Published 2014-12-31

References

1. Eden T. Steroids in ALL. In: Agarwal BR, Perilongo G, Wacker P, Eden T, editors. SIOP education book 2006: 38th Congress of the International Society of Paediatric Oncology; 2006 Sep 17-21; Geneva, Switzerland. p.12-6.
2. Inaba H, Pui CH. Glucocorticoid use in acute lymphoblastic leukemia: comparison of prednisone and dexamethasone. Lancet Oncol. 2010;11:1096-106.
3. Gaynon PS, Lustig RH. The use of glucocorticoids in acute lymphoblastic leukemia of childhood. Molecular, cellular, and clinical considerations. J Pediatr Hematol Oncol. 1995;17:1-12.
4. Olgar S, Yetgin S, Cetin M, Aras T. Can renal leukemic infiltration cause hypertension in children? J Pediatr Hematol Oncol. 2006;28:579-84.
5. Howard SC, Jones DP, Pui CH. The tumor lysis syndrome. N Engl J Med. 2011;364:1844-54.
6. Attard-Montalto SP, Saha V, Ng YY, Kingston JE, Eden OB. High incidence of hypertension in children presenting with acute lymphoblastic leukemia. Pediatr Hematol Oncol. 1994;11:519-25.
7. Louis CU, Butani L. High blood pressure and hypertension in children with newly diagnosed acute leukemia and lymphoma. Pediatr Nephrol. 2008;23:603-9.
8. Feld LG, Corey H. Hypertension in childhood. Pediatr Re. 2007;28:283-98.
9. Saing JH. Hipertensi pada remaja. Sari Pediatri. 2005;6:159- 65.
10. Sekarwarna N, Rachmadi D, Hilmanto D. Rekomendasi tata laksana hipertensi pada anak. Konsensus tata laksana hipertensi pada anak. Unit Kerja Koordinasi Nefrologi IDAI. Jakarta: IDAI; 2011. p.2-5.
11. Supartha M, Suarta IK, Winaya IBA. Hipertensi pada anak. Maj Kedok Indon. 2009;59:221-30.
12. Varda NM, Gregoric A. A diagnostic approach for the child with hypertension. Pediatr Nephrol. 2005;20:499-506.
13. Belgaumi AF, Al-Bakrah M, Al-Mahr M, Al-Jefri A, Al-Musa A, Saleh M, et al. Dexamethasone-associated toxicity during induction chemotherapy for childhood acute lymphoblastic leukemia is augmented by concurrent use of daunomycin. Cancer. 2003;97:2898-903.
14. Feig DI, Johnson RJ. Hyperur icemia in childhood primary hypertension. Hypertension. 2003;42:247-52.
15. Heinig M, Johnson RJ. Role of uric acid in hypertension, renal disease, and metabolic syndrome. Cleve Clin J Med. 2006;73:1059-64.